Diabetes Drug Now Approved for Heart Failure

The diabetes drug empagliflozin (Jardiance) is now approved to reduce the risk of cardiovascular death and hospitalization in adults with heart failure, even if they do not have diabetes.Nurses and NPs should monitor patients for adverse effects, especially fluid deficits.
Source: AJN - Category: Nursing Tags: Drug Watch Source Type: research